We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Breastfed babies might very rarely develop side-effects due to the presence of morphine in breast milk.
MHRA reclassifies Otrivine Extra Dual Relief Nasal Spray Solution
A skin cream claiming to be a natural Chinese herbal remedy for treating eczema, contains a potentially harmful steroid and should not be used, warns the Medicines and Healthcare products Regulatory Agency (MHRA).
The government is collaborating with pharmaceutical company Novartis to launch a clinical trial for new cholesterol treatment.
First published during the 2015 to 2016 Cameron Conservative government
An innovative cell therapy for cancer has become the first designated ‘promising’ as part of a scheme to get medicines to patients quicker.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Two suppliers of the antidepressant, nortriptyline, have admitted illegally sharing information in order to keep prices up.
The CMA provisionally finds Auden Mckenzie and Waymade broke the law by agreeing not to compete for the supply of hydrocortisone tablets to the NHS.
Do not use codeine in children under 12 as it is associated with a risk of respiratory side effects. Codeine is not recommended for adolescents (12 to 18) who have problems with breathing.
People who use emollient creams to treat dry and itchy skin conditions are being warned that residue can build up on fabrics, such as clothing or bedding, and cause them to catch fire more easily.
The CMA has provisionally found that 4 pharmaceutical companies broke the law by agreeing not to compete in the supply of an anti-nausea drug in the UK.
Letter from the DH Offender Health team and the National Research Committee
Employment Tribunal decision.
(McNeil Products Limited) Remaining stocks of the above products should be quarantined - class 2 action within 48 hours. (EL (14)A/14)
New simplified guidance on treating paracetamol overdose with intravenous acetylcysteine including an updated treatment nomogram.
In February 2012, the National Prescribing Centre (NPC) published an update.
Public consultation launched on the continued availability of oral diclofenac as a pharmacy (P) medicine and on risk-minimisation measures advised by the Commission on Human Medicines.
New controls over prescription drugs pregabalin and gabapentin following rising fatalities.
First published during the 2016 to 2019 May Conservative government
The CMA has provisionally found that 4 pharmaceutical companies broke competition law in relation to the supply of an anti-depressant drug.
Paul Beddoes has had the minimum term for his life sentence increased under the Unduly Lenient Sentence Scheme.
Confidential reports designed to help you improve the quality of your prescribing and patient safety are now available for practices that contribute to the MHRA’s Clinical Practice Research Datalink.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).